Preclinical and Clinical Bioanalytical Services
Synomics Pharma provides the bioanalytical services of a large laboratory with the agility, flexibility, and personalized approach of smaller organizations. Our bioanalytical testing offerings include preclinical bioanalysis, clinical bioanalysis, plasma analysis, discovery bioanalysis, metabolism analysis, CYP450 analysis, forced degradation, and in vitro metabolite ID.
We are uncompromising in our commitment to producing studies of the highest quality, completed to your specifications and timeline, while continually keeping you informed. 
Bioanalytical Chemistry Services
- Identification of metabolites
- GLP and non-GLP bioanalysis services
- Customized LC/MS/MS method development with strategies to ensure robustness
- Stage-specific LC/MS/MS validation in accordance with FDA guidelines and industry best practices
- Sample analysis for clinical and pre-clinical studies
- Biomarker services
- Forced degradation
- Continually expanding list of validated methods for non-proprietary compounds
Expertise
Proteins and Peptides
- Client specific compounds (Oncology & Neurological)
- Glycosylated Peptides/proteins (HPLC Coronal Aerosol Detector & LC/MS/MS)
Small Molecule
- Oncology
- Hormones/prostaglandins
- Diabetes
- Tetracycline derivatives
- Blood thinners
- Statin derivatives
- Anti-inflammatory
- Neurological
- Vitamin D derivatives
Stages of Development
- Discovery (Non-GLP)
- Pre-clinical (GLP)
- Clinical (GLP/GMP)
